1. Introduction {#sec1}
===============

Werner syndrome (WS) is a rare autosomal recessive disease associated with premature age-related phenotypes such as cancer, osteoporosis, diabetes mellitus and early graying of the hair (review \[[@B1]\]). The gene responsible for WS (*WRN*) is one of a five human RecQ helicases including BLM, RECQL1, RECQL4, and RECQ5. Like WS, the absence of BLM and RECQL4 gives rise to the clinically distinct diseases, Bloom\'s syndrome (BS) and Rothmund-Thomson syndrome, respectively. Although a variety of different *WRN* mutations have been discovered, many result in a truncated nonfunctional WRN (summarized in \[[@B2]\]). Cells from WS patients depict an aging phenotype including reduced proliferation associated with an increase in S-phase \[[@B3]\] and early passage senescence \[[@B3], [@B4]\]. Furthermore, WS cells show increased levels of genomic instability thought be caused from increased levels of illegitimate recombination. These observations lead us to investigate the role of WRN *in vivo*.

For this study we used a WRN mouse model with a deleted helicase domain \[[@B5]\] in combination with the well-established murine pink-eyed unstable (*p*^un^) mouse model that can be used to determine changes in the spontaneous frequency of somatic homologous recombination (HR) events \[[@B6]--[@B8]\]. Though rare, this particular *Wrn* mutation has been found in a small population of WS patients \[[@B9], [@B10]\] and is therefore relevant to the human disease. The *p*^un^ assay is based on an HR-mediated deletion of one copy of a 70 kb DNA duplication that encompasses exons 6--18 of the *p* gene \[[@B11]\]. The exact deletion of one copy of the repeated region will restore the function of this pigmentation gene, and this can be observed as somatic events in pigmented tissues such as the fur and the retinal pigment epithelium (RPE) \[[@B8], [@B12]\]. The further development of the *p*^un^ eye spot assay which identifies *p*^un^ reversion events on a monolayer of clear RPE cells has proven to be significantly more sensitive and informative than the fur spot assay \[[@B6]\].

Studies in yeast using a similar duplication/deletion assay to the *p*^un^ reversion assay have identified several possible mechanisms of HR that may mediate this type of deletion event. These include intrachromatid exchange, one-sided strand invasion, unequal sister chromatid exchange (SCE), sister chromatid conversion, and single-strand annealing (SSA) \[[@B13]\]. Excluding SSA, each of these HR mechanisms is considered RAD51-dependent. RAD51-dependent HR is considered a high fidelity DNA repair mechanism that is frequently associated with DNA replication (review \[[@B14]\]). For example, replication forks can stall or collapse when the replication machinery encounters DNA damage like a single strand break, and HR is capable of repairing the damaged DNA template and restoring the replication fork \[[@B15]\]. Claybon et al. recently reported that in the absence of PARP1, somatic HR events, measured by the *p*^un^ system, are highly elevated and that a majority of these events were large clonally expanded cells \[[@B44]\]. These authors went on to suggest that these clonally expanded populations of cells are the result of an HR-mediated deletion that occurred during replication, probably in a RAD51-dependent mechanism (as compared to SSA). The utility of the helicase domain of mouse WRN is discussed below.

2. Materials and Methods {#sec2}
========================

2.1. Mouse Lines and PCR Genotyping {#sec2.1}
-----------------------------------

WRN helicase mutant (Wrn^Δhel/+^) \[[@B5]\] mice on an FVB strain background were obtained from Dr. P. Leder, and C57BL/6J and C57BL/6J *p*^un^/^un^ mice were obtained from the Jackson Laboratory (Bar Harbor, ME). In order to obtain congenic C57BL/6J *p*^un^/^un^Wrn^Δhel/+^ mice (hereafter called Wrn^Δhel/+^), Wrn^Δhel/+^ mice were backcrossed 5 times to C57BL/6J followed by two additional crosses to C57BL/6J *p*^un/un^ mice. All mice were maintained with *p*^un/un^ mutation. Control (*Wrn^+/+^*) and experimental (Wrn^Δhel/Δhel^) animals result from crossing Wrn^Δhel/+^mice together. The *p*^un/un^ allele was genotyped by the identification of the phenotypic dilute coat color. Genotypes for the *Wrn* allele were determined by a PCR amplification protocol obtained from Aya Leder, Harvard Medical School, MA consisting of the following 3 primers: (1) 5′-GTTTCCTCTATCATCTGTAACAGG-3′, (2) 5′-GCGAAGGAGCAAAGCTGCTAT-3′ and (3) 5′-AGTGAGACATGTATGACTACC-3′ and the thermo profile: 1 cycle of 94°C for 5 min; 30 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min; 1 cycle of 72°C for 3 min. Amplicon size for the wt PCR product is 350 bp and *Wrn* mutant 450 bp. When necessary, genomic DNA was isolated from fixed RPE using the Qiagen DNeasy Blood and Tissue kit according to manufacture\'s recommendations.

2.2. Dissection, Visualizing, and Scoring Eye Spots on the Retinal Pigment Epithelium {#sec2.2}
-------------------------------------------------------------------------------------

Harvesting of the eye and dissection of the RPE were carried out as previously described in \[[@B7]\]. RPE whole mounts were visualized and imaged using a Zeiss Lumar V.12 stereomicroscope, Zeiss Axiovision MRm camera, and Zeiss Axiovision 4.6 software (Thornwood, NY). *p*^un^ reversion events were identified on the transparent monolayer of the RPE as pigmented cells or eye spots. Total number of eye spots and number of cells making up that eye spot were recorded for each RPE according to the criteria set forth by Bishop et al. in \[[@B7]\]. Additionally, the relative distance from the optic nerve of each eye spot was recorded. This was done by using the measurement tool in Adobe Photoshop, by first measuring from the center of the optic nerve to the proximal edge of the eye spot and then from the center of the optic nerve to the edge of the RPE. The relative distance is then determined by dividing the former by the latter.

2.3. Statistical Analysis {#sec2.3}
-------------------------

All statistics were carried using GraphPad Prism (La Jolla, CA). These include tests for normality (Shapiro-Wilk test), equal variances (Fmax test), two group comparisons (Mann-Whitney test), and contingency tables (Fisher\'s exact test).

3. Results {#sec3}
==========

3.1. Loss of WRN Helicase Activity Does Not Affect the Overall Frequency of Spontaneous Homologous Recombination in Mouse RPE In Vivo {#sec3.1}
-------------------------------------------------------------------------------------------------------------------------------------

The frequency of spontaneous HR for mice with helicase domain-deficient WRN protein was previously reported as being increased 2-fold using the *p*^un^ fur spot assay \[[@B16]\]. Though the *p*^un^ fur spot assay can be considered a faithful assay for measuring HR frequency *in vivo*, the *p*^un^eye spot assay affords many advantages, including being more sensitive to changes in HR frequency \[[@B8]\] and can reveal information about the timing of events during development \[[@B7]\], developmental patterning \[[@B17]\], and even information about whether the HR events are associated with replication \[[@B44]\]. Therefore, we set out to recapitulate the fur spot study and to determine whether we might be able to reveal any additional phenotypes associated with the WRN^Δhel^ HR events. Surprisingly, when we compared the number of eye spots per RPE in Wrn^+/+^ versus Wrn^Δhel/Δhel^ ([Table 1](#tab1){ref-type="table"}and [Figure 2(a)](#fig2){ref-type="fig"}), we were unable to detect a significant increase in the overall frequency of HR events (*P* = .35, Mann-Whitney test) ([Figure 2(b)](#fig2){ref-type="fig"}). The nonparametric Mann Whitney test was used because our data was found to be not normal (data not shown) with unequal variances using a Fmax test (*P* \< .0001). Of interest, the variance within the*Wrn^+/+^* RPE was larger than expected due to three RPEs with higher than usual numbers of reversion events. To determine whether the lack of difference in HR frequency between *Wrn^+/+^*and Wrn^Δhel/Δhel^ was due to the wild-type RPE with elevated HR frequency, we compared the frequency of eye spots of our WRN wild-type RPEs with an independent wild-type data set that was recently reported by our laboratory \[[@B44]\]. No statistical difference in *p^un^* reversion frequency was observed between these two groups of wild-type RPE (data not shown). We therefore combined these wild-type datasets, compared their combined *p^un^* reversion eyespot frequency with Wrn^∆hel/∆hel^, and still did not observe any statistical difference between genotypes ([Figure 2(b)](#fig2){ref-type="fig"}). Therefore, it appears that WRN helicase activity is not required for HR, and no additional HR events are instigated by the WRN mutation.

3.2. Single- and Multicell Eye Spots in Mouse RPE Are Not Affected by WRN Helicase {#sec3.2}
----------------------------------------------------------------------------------

We classify eye spots as having either single (1 cell) or multi-cell (≥2 cells) events \[[@B8]\]. Due to the edge-biased proliferation of the RPE \[[@B18]\] and the apparent "position shift" between single-cell and multi-cell eye spots \[[@B7]\], we speculate that multi-cell (clonally expanded) *p*^un^ reversion events are associated with DNA replication (discussed below). Approximately 60% of eye spots are normally single cell events. Even though we did not observe an overall difference in HR frequency, we wanted to see if WRN helicase activity affected the clonal expansion of *p*^un^ reversion events. Here we found no significant difference between single versus multi-cell eye spots when comparing Wrn^+/+^ versus Wrn^Δhel/Δhel^ RPE (*P* = .39, Fisher\'s exact test Figure (3)). These data indicate that the helicase activity of WRN does not affect clonal expansion of mouse RPE cells following HR.

3.3. Distribution of HR Events during RPE Development Is Not Affected by WRN Helicase Mutation {#sec3.3}
----------------------------------------------------------------------------------------------

The mouse RPE develops radially outward from the optic nerve with an edge-biased pattern of proliferation \[[@B18]\]. The RPE begins to form in the developing eye cup at \~8.5 dpc and continues through the first week of postnatal development \[[@B19], [@B20]\]. Much like the age of a tree that can be determined using its concentric rings, the retrospective mapping of an eye spot onto an RPE suggests when during development a *p*^un^ reversion event occurred \[[@B7]\]. Previously we have reported mutant genotypes that affected either the timing of *p*^un^ reversion events during RPE development or the pattern of RPE development by examining eye spot patterns \[[@B6], [@B17]\]. In order to determine if WRN helicase function has a role in HR at a specific point during murine development, each RPE was divided into 10 concentric rings where the inner most ring contains the optic nerve depicting the beginning of RPE development (0.0-0.1) to the outer most ring at the edge of the RPE (0.9-1.0). At each interval, the pattern of positional distribution was similar for both Wrn^+/+^ and Wrn^Δhel/Δhel^ for all eye spots (*P* = .22, Chi-square test, [Figure 4](#fig4){ref-type="fig"}). Of note, the positional analysis of the eye spots measures the distance from the center of the optic nerve to the most proximal cell of an eye spot, irrespective of the number of cells that constitutes the eye spot. These results suggest that the effect of the WRN helicase mutation on HR does not alter the timing or distribution of *p*^un^ reversion events during mouse RPE.

4. Discussion {#sec4}
=============

In summary, mice expressing a helicase-deficient *Wrn* allele did not have an increase in the frequency of spontaneous HR. Our results differ substantially from earlier work done using this same mouse model with the less sensitive *p*^un^ fur spot assay which observed at least a 2-fold increase in *p*^un^ reversion events \[[@B16]\]. In our experience we have never observed a discrepancy in *p*^un^ reversion frequency between the neural crest-derived melanocyte-dependent fur spot assay and the neural epithelium-derived RPE-based eye spot assay.

However, it should be noted that we have not examined the frequency of *p*^un^ fur spots in our C57BL6/J congenic animals, and it is formally possible that the difference may be due to difference in strain background. Our result also differs from a more recent report using the *p*^un^ eye spot assay with the expression of a transgenic dominant negative human *WRN* allele \[[@B21]\]. This latter report observed a 30% increase in eye spots (from an average of 6 to 8 eye spots per RPE in wild-type and WRN impaired, resp.), a relatively slight, though significant increase for the *p*^un^ eye spot assay, that could be simply explained by sample size; Yamamoto et al. \[[@B21]\] used approximately 50 RPE per group compared to our 20 RPE. Alternately, the difference could be due to a difference in using a mouse helicase deficient *Wrn* mutant mouse and a mouse model that expressed a transgenic dominant negative allele of human WRN.

The *p*^un^ fur spot assay is reliant upon detecting large clonal expansions of melanocytes following *p*^un^ reversion that are visible in the fur (at least 1 mm^2^). In contrast, the *p*^un^ eye spot assay can detect both single cell and clonally expanded (multi-cell) reversion events. Additionally, the *p*^un^ eye spot assay can be used to determine any differences in the timing of HR events during embryonic development. In this study we found that the helicase activity of mouse WRN does not affect the frequency of single versus multi-cell events and nor does it affect the timing of spontaneous HR events during mouse embryonic development.

Although WS cells are described as having genomic instability, there is some discrepancy as to the role WRN plays in HR. In support of WRN as a suppressor of illegitimate HR, WS patients exhibit variegated chromosomal translocations \[[@B22]\], elevated recombination levels between microhomology plasmids \[[@B23]\], approximate 2-fold increase of RAD51 focus formation \[[@B24]\], and sensitivity to agents that lead to replication stress \[[@B5], [@B25]--[@B27]\]. Additionally, WRN is known to associate with proteins tied to replication machinery like RPA \[[@B28]--[@B31]\], PCNA \[[@B32]--[@B34]\], Pol*δ* \[[@B35], [@B36]\], and RAD52 \[[@B37]\]. In contrast though, WS cells do not have elevated amounts of SCE which are the hallmark of BS \[[@B38]\].

More recent studies have begun to show that RecQ helicases (e.g., WRN) promote HR via mechanisms like DNA resection. Following double-strand breaks (DSBs), the helicase domain of Sgs1 (yeast RecQ orthologue of WRN) is required for resection of DNA ends to produce single strand DNA substrates for RAD51 \[[@B39], [@B40]\]. Additionally, the helicase function of Sgs1 is required for normal kinetics of HR at the *MAT* locus, and yeast mutants for Sgs1 and Exo1 nuclease exhibit sensitivity to DNA damaging at similar levels to Rad52 mutants (which are diminished for HR repair) \[[@B41]\]. These same authors subsequently went on to demonstrate that the RecQ helicase BLM also has some DNA resection functions following Camptothecin-induced DSBs and that BLM function of DSB resection is in parallel with an EXO1-dependent pathway \[[@B41]\]. A separate study investigated the role of WRN following exposure to chromium(VI), an agent known to induce DSBs, and found that chromium(VI) treated human cells depleted of WRN and WS cells had delayed or absent RAD51 focus formation \[[@B42]\]. This study again suggests that WRN is important for promoting HR, potentially in early steps of this process (e.g., initiation via resection) following DNA damage. Unlike the other human RecQ helicase members, WRN also has exonuclease activity, so understanding which enzymatic function of WRN is involved in promoting HR is valuable to our knowledge of this protein, as well as insightful to the syndrome. As it pertains to this study, we found that the helicase function of WRN is neither necessary for, nor suppresses spontaneous HR. With regard to other RecQ helicases, we recently found HR to be significantly elevated in the absence of BLM using the *p*^un^ eye spot assay (data not shown). Considering the lack of effect observed in our study, and only a mild suppressive effect in the Yamamoto et al. study \[[@B20]\] compared to a deficiency in BLM (data not shown), it would appear that WRN only plays a minor role in suppressing HR, possibly the result of redundancy amongst the different RecQ family members. Together, these studies give insight into the potential differences between two of the known five human RecQ helicases and suggest that future studies are warranted to better understanding the functions of WRN (and BLM) in HR.
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![HR-mediated reversion of the *p*^un^ allele. Schematic of the *p*^un^ mutation (tandem duplication of exons 6--18), where an HR event mediates the deletion of one copy rendering a functional *p* gene allowing pigmentation of RPE cells. Circles and arrowheads represent centromere and telomere DNA, respectively.](JNA2010-356917.001){#fig1}

![Frequency of HR in mouse RPE. (a) Population distribution of eye spots per RPE in wild-type (open boxes) and Wrn^Δhel/Δhel^ (grey boxes). (b) Overall frequency of eye spots per RPE shown as a box and whisker plot. No statistical difference in HR was detected between wild-type and Wrn^Δhel/Δhel^ groups (*P* = .35).](JNA2010-356917.002){#fig2}

![Frequency of the different sizes of eye spot (number of cells per eye spot) in mouse RPE. Wrn^Δhel/Δhel^ (grey boxes) does not affect cell size distribution compared to wild-type (open boxes) (*P* = .39).](JNA2010-356917.003){#fig3}

![Positional distribution of all eye spots. WRN helicase does not affect positional or pattern distribution (*P* = .22). Wild type (open circles with dash line) and Wrn^Δhel/Δhel^ (closed circles with solid line) RPE.](JNA2010-356917.004){#fig4}

###### 

Summary of RPE examined and *p*^*un*^ reversion frequency by *Wrn*genotype.

  Genotype         Number of RPE   Total number of eye spots   Avg. number of eye spots per RPE   Avg. eye spot size (cell number)
  ---------------- --------------- --------------------------- ---------------------------------- ----------------------------------
  *Wrn^+/+^*       53              522                         10                                 6
  Wrn^Δhel/Δhel^   20              152                         8                                  4
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